Leqvio (inclisiran) - Novartis
Praluent (alirocumab) - Sanofi, Regeneron
Repatha (evolocumab) - Amgen, Astellas
lerodalcibep (LIB003) - LIB Therap
http://www.ncbi.nlm.nih.gov/pubmed/40202526
 
Dimitrios Tsiachris; Konstantinos Pamporis; Paschalis Karakasis
 
Apr 9, 2025
 
Next